Pulmonary Hypertension News and Research

RSS
Pulmonary arterial hypertension (PAH) is a condition involving high blood pressure and structural changes in the walls of the pulmonary arteries, which are the blood vessels that connect the right side of the heart to the lungs. Affecting people of all ages and ethnic backgrounds - but most commonly found in young women of child-bearing years - the disease has historically been chronic and incurable, with a poor survival rate. PAH is often not diagnosed in a timely manner because its early symptoms can be confused with those of many other pulmonary and respiratory conditions. Symptoms include shortness of breath, extreme fatigue, dizziness, fainting, swollen ankles and legs and chest pain (especially during physical activity). With proper diagnosis, there are currently several therapies to alleviate symptoms and improve quality of life for PAH patients. The key is to find a PAH specialist and pursue immediate treatment.
Deep vein clots in critical COVID-19 illness

Deep vein clots in critical COVID-19 illness

UCI Health to initiate clinical trial of a drug to treat critically ill COVID-19 patients

UCI Health to initiate clinical trial of a drug to treat critically ill COVID-19 patients

Study: Chronic exposure to inhaled nicotine alone leads to pulmonary hypertension

Study: Chronic exposure to inhaled nicotine alone leads to pulmonary hypertension

C-Path receives EMA’s letter of support to facilitate the diagnoses of type 1 diabetes

C-Path receives EMA’s letter of support to facilitate the diagnoses of type 1 diabetes

COVID-19 and immunodeficiency

COVID-19 and immunodeficiency

ATS publishes first official clinical practice guidelines for sarcoidosis

ATS publishes first official clinical practice guidelines for sarcoidosis

China with the world: COVID-19 experts dialogues - the 2nd talk transcript

China with the world: COVID-19 experts dialogues - the 2nd talk transcript

Validation of a better risk stratification system for bronchopulmonary dysplasia

Validation of a better risk stratification system for bronchopulmonary dysplasia

New inhalation therapy could relieve lung fibrosis in mice and rats

New inhalation therapy could relieve lung fibrosis in mice and rats

NTHU research team develops new treatment for cancer

NTHU research team develops new treatment for cancer

Gut bacteria may predict risk of pulmonary hypertension

Gut bacteria may predict risk of pulmonary hypertension

Specific gut bacteria may predict development of pulmonary arterial hypertension

Specific gut bacteria may predict development of pulmonary arterial hypertension

Study explores how the human lung develops at single cell level

Study explores how the human lung develops at single cell level

Identifying respiratory diseases causing pulmonary hypertension can lead to improved outcomes

Identifying respiratory diseases causing pulmonary hypertension can lead to improved outcomes

Physiologists, researchers to discuss factors underlying cardiovascular disease at APS conference

Physiologists, researchers to discuss factors underlying cardiovascular disease at APS conference

New ESC guidelines for diagnosis and management of pulmonary embolism published

New ESC guidelines for diagnosis and management of pulmonary embolism published

Inflammation in the lungs triggers silent mutation to cause pulmonary hypertension

Inflammation in the lungs triggers silent mutation to cause pulmonary hypertension

New study questions the presumptions about LVADs and mitral regurgitation

New study questions the presumptions about LVADs and mitral regurgitation

UW Medicine achieves milestone of 1,000 lung transplants

UW Medicine achieves milestone of 1,000 lung transplants

Exploring the heart at a depth that was previously impossible

Exploring the heart at a depth that was previously impossible